5406 篇
13915 篇
478166 篇
16325 篇
11773 篇
3946 篇
6553 篇
1254 篇
75690 篇
38001 篇
12189 篇
1671 篇
2871 篇
3423 篇
642 篇
1242 篇
1980 篇
4926 篇
3888 篇
5503 篇
墨西哥制药和医疗保健行业报告(2019-2020年)
Mexico Pharma and Healthcare Sector Report 2019-2020
The level of competition in the pharma and healthcare sector varies across segments. A relatively high degree of competition is observed in the pharmaceutical manufacturing, with 795 active companies as of March 2018, of which 13% large enterprises with more than 250 employees. On the other hand, as of the same month, there were 93,313 pharmacies in Mexico. Yet, the pharmaceutical retail exhibits a moderate degree of competition, as five medium-sized chains accounted for 54.4% of the drug retail sales in 2017. The health insurance in Mexico is virtually monopolised by the government, with only a small private health insurance system offering some choice for consumers.
01 EXECUTIVE SUMMARY
02 SECTOR IN FOCUS
03 COMPETITIVE LANDSCAPE
04 COMPANIES IN FOCUS
05 REGULATORY ENVIRONMENT
06 PHARMACEUTICALS
07 HEALTHCARE
08 RETAIL CHANNELS